Gh Research PLC

Form 420-F13G

Insider Trading (Form 4)

NASDAQ
GHRS
Gh Research PLC
Form 4: GH Research Director Receives Stock Grant
Duncan Moore, a Director of GH Research PLC, received 2,202 shares of common stock on August 11, 2026.
NASDAQ
GHRS
Gh Research PLC
Form 4: GH Research Director Receives Stock Grant
Dermot John Hanley, a Director of GH Research PLC, received 2,202 shares of common stock on August 11, 2026.
NASDAQ
GHRS
Gh Research PLC
Form 4: GH Research Director Receives Stock Grant
Michael Forer, a Director of GH Research PLC, reported multiple transactions in common stock on August 11, 2026.

Schedule 13G - Passive Investments

See all →
NASDAQ
GHRS
Gh Research PLC
SCHEDULE: RA Capital Discloses 7.1% Stake in GH Research PLC
RA Capital Management, along with its affiliates, has reported beneficial ownership of 7.1% of GH Research PLC's ordinary shares, totaling 4,897,182 shares.
NASDAQ
GHRS
Gh Research PLC
SCHEDULE: Lynx1 Capital Management Reports 19.3% Stake in GH Research
Lynx1 Capital Management LP and Weston Nichols have disclosed a beneficial ownership of 13,263,288 ordinary shares, representing 19.3% of GH Research PLC.
NASDAQ
GHRS
Gh Research PLC
SCHEDULE: Lynx1 Capital Increases Stake in GH Research PLC
Lynx1 Capital Management LP and Weston Nichols have disclosed a 17.4% beneficial ownership stake in GH Research PLC.
NASDAQ
GHRS
Gh Research PLC
SCHEDULE: Lynx1 Capital Discloses 15.2% Stake in GH Research
Lynx1 Capital Management LP and Weston Nichols have reported a 15.2% beneficial ownership stake in GH Research PLC.
NASDAQ
GHRS
Gh Research PLC
SCHEDULE: Lynx1 Capital Boosts GH Research Stake to 16.8%
Lynx1 Capital Management LP and Weston Nichols have increased their beneficial ownership in GH Research PLC to 16.8% of outstanding shares.
NASDAQ
GHRS
Gh Research PLC
SCHEDULE: Terwey Reports 2.9% Stake in GH Research PLC
Theis Terwey has reported a 2.9% beneficial ownership stake in GH Research PLC, holding 1,784,266 ordinary shares.